Samsung Biologics Co., a biotech arm of South Korea's Samsung Group, said Thursday it plans to spin off its biosimilar ...

The expansion adds 8,075 square feet of state-of-the-art GMP manufacturing space to the San Diego biologics manufacturing ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

Explore Terumo's steady growth, strong market leadership, and disciplined expansion. A reliable med-tech investment with long ...

Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the ...

The company has increased manufacturing capacity from pilot scale to 1 million liters annually, and can now assist customers ...

Genmab says choosing to insource cell-line development helped them to improve the antibody titers they were achieving.

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Optieum ...

WuXi Biologics is giving CDMO Terumo the keys to its site in Leverkusen, Germany, with a 150 million euros ($167 million) ...

In collaboration with Pacific Biosciences, scientists at the Wellcome Sanger Institute will harness these advancements to explore how gene activity shapes the human immune system at single-cell ...